Please login to the form below

Not currently logged in
Email:
Password:

trial data

This page shows the latest trial data news and features for those working in and with pharma, biotech and healthcare.

Trial data suggest Abivax’ drug may clear latent HIV

Trial data suggest Abivax’ drug may clear latent HIV

Trial data suggest Abivax’ drug may clear latent HIV. ABX464 reduced HIV DNA in peripheral blood CD4 cells by up to 52% over 28 days. ... The preliminary data suggest the trial “should form a strong platform for movement into a phase IIb study.”.

Latest news

More from news
Approximately 45 fully matching, plus 660 partially matching documents found.

Latest Intelligence

  • Brave real world? How healthcare communication needs to adapt Brave real world? How healthcare communication needs to adapt

    the stresses and strains of the real world. So how do we ensure that HCPs, regulators and patients understand and value data that has been collected outside a clinical trial? ... Being able to discuss the value of collecting all data and the limitations

  • Protecting patient privacy Protecting patient privacy

    clinical trial data. ... Phase 2 of Policy 0070, which will require that life science companies provide anonymised copies of all of their clinical trial data, is coming down the line, albeit that currently there

  • The rise of real-world evidence The rise of real-world evidence

    The rise of real-world evidence. Demonstrating efficacy and value requires more than clinical trial data. ... Whatever technology patients are using, we have a way to pull in that data.

  • Deal Watch January 2018

    The company switched focus to its JCAR017 programme and recently reported promising data in a pivotal trial for relapsed and/or refractory diffuse large B-cell lymphoma (DLBCL). ... Tucatinib is currently being evaluated in a phase II pivotal trial in

  • A catalyst for change A catalyst for change

    According to this draft, overseas clinical trial data provided by the MAHs for the drug registration in China shall be complete, correct, true and traceable. ... The process of obtaining the overseas clinical trial data shall comply with both Good

More from intelligence
Approximately 0 fully matching, plus 37 partially matching documents found.

Latest appointments

  • Clinerion appoints new regional head Clinerion appoints new regional head

    Clinerion appoints new regional head. Bariş Erdoğan takes up new role at the clinical trial data firm. ... Swiss-based clinical trial data firm Clinerion has appointed Bariş Erdoğan as its new regional head in a role that focuses on the expansion of

  • Sanofi CEO Viehbacher to head EFPIA Sanofi CEO Viehbacher to head EFPIA

    One of the most pressing matters for EFPIA is the seemingly inevitable trend towards transparency of trial data, and Viehbacher has already commented on the subject.

  • Eric Green named NIH's data science lead Eric Green named NIH's data science lead

    Eric Green named NIH's data science lead. Takes role on interim basis as part of expanding plans for data. ... This project offers a data repository with demographics, clinical observations, clinical trial outcomes, adverse events and biomarker data like

  • Almac appoints Charlie Morris as VP new products and services in clinical technologies division Almac appoints Charlie Morris as VP new products and services in clinical technologies division

    According to the company, which provides services to the pharma industry, he will oversee the development of its IXRS technology to manage patients, supplies, and clinical trial data.

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • How pembrolizumab will change the management of advanced lung cancer

    Further, the tolerability was in favor of pembrolizumab. We talked Dr Martin Reck about the trial. ... He explains that “ this data will completely change our management of patients with advanced lung cancer”.

  • The Heart of the Matter 7: Reality Dawns

    The challenge is to turn that data into information and information into insight. ... In tandem, as the limitations of the 'gold standard' randomised clinical trial (RCT) data are increasingly exposed, European initiatives such as the Innovative

  • The Heart of the Matter 9: Context is King

    Flagship policy in both Europe and the US is mandating the full disclosure of clinical trial data, while international regulations now dictate data sharing, including anonymised individual-patient data, across all ... Although these approaches are still

  • Oncology drugs under AMNOG

    This often means that manufacturers will only have trial data for part of the label population (based on a single phase 3 trial). ... There is also a risk that if the trial population is segmented and data has not been collected for the relevant segments

  • Clinical data Transparency

    As the date for legislation approaches, each week brings more debate regarding the issue of clinical data transparency. ... But despite simplistic reporting, the issue of increasing the transparency of data from clinical trials contains complexities not

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics